Deutsche Bank’s Foamix Pharmaceuticals Ltd. Ordinary Shares FOMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-10,898
| Closed | -$33K | – | 4935 |
|
|
2019
Q3 | $33K | Sell |
10,898
-178,613
| -94% | -$541K | ﹤0.01% | 3986 |
|
|
2019
Q2 | $450K | Buy |
189,511
+175,930
| +1,295% | +$418K | ﹤0.01% | 3301 |
|
|
2019
Q1 | $50K | Buy |
+13,581
| New | +$50K | ﹤0.01% | 4353 |
|
|
2018
Q4 | – | Sell |
-5,870
| Closed | -$34K | – | 5018 |
|
|
2018
Q3 | $34K | Sell |
5,870
-24,696
| -81% | -$143K | ﹤0.01% | 4520 |
|
|
2018
Q2 | $153K | Buy |
30,566
+20,001
| +189% | +$100K | ﹤0.01% | 4248 |
|
|
2018
Q1 | $54K | Buy |
10,565
+1,859
| +21% | +$9.5K | ﹤0.01% | 4465 |
|
|
2017
Q4 | $52K | Sell |
8,706
-8,436
| -49% | -$50.4K | ﹤0.01% | 4122 |
|
|
2017
Q3 | $94K | Sell |
17,142
-91,080
| -84% | -$499K | ﹤0.01% | 3982 |
|
|
2017
Q2 | $502K | Buy |
108,222
+60,324
| +126% | +$280K | ﹤0.01% | 3361 |
|
|
2017
Q1 | $236K | Buy |
47,898
+27,261
| +132% | +$134K | ﹤0.01% | 3367 |
|
|
2016
Q4 | $229K | Sell |
20,637
-6,632
| -24% | -$73.6K | ﹤0.01% | 3462 |
|
|
2016
Q3 | $252K | Sell |
27,269
-62,396
| -70% | -$577K | ﹤0.01% | 3419 |
|
|
2016
Q2 | $569K | Buy |
89,665
+35,586
| +66% | +$226K | ﹤0.01% | 3155 |
|
|
2016
Q1 | $351K | Sell |
54,079
-4,090
| -7% | -$26.5K | ﹤0.01% | 3319 |
|
|
2015
Q4 | $470K | Sell |
58,169
-13,637
| -19% | -$110K | ﹤0.01% | 3228 |
|
|
2015
Q3 | $524K | Buy |
71,806
+19,797
| +38% | +$144K | ﹤0.01% | 3266 |
|
|
2015
Q2 | $532K | Buy |
+52,009
| New | +$532K | ﹤0.01% | 3281 |
|
|
2015
Q1 | – | Sell |
-34,499
| Closed | -$241K | – | 5441 |
|
|
2014
Q4 | $241K | Buy |
34,499
+1,890
| +6% | +$13.2K | ﹤0.01% | 3998 |
|
|
2014
Q3 | $177K | Buy |
+32,609
| New | +$177K | ﹤0.01% | 3941 |
|